Author:
Groenland Stefanie L.,van Nuland Merel,Verheijen Remy B.,Schellens Jan H. M.,Beijnen Jos H.,Huitema Alwin D. R.,Steeghs Neeltje
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference65 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30.
2. Committee for Medicinal Products for Human Use European Medicines Agency. Abiraterone European public assessment report. 2011.
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002321/WC500112858.pdf
. Accessed 26 May 2018.
3. Verheijen R, Yu H, Schellens J, Beijnen J, Steeghs N, Huitema A. Practical recommendations for therapeutic drug monitoring of kinase inhibitors in oncology. Clin Pharmacol Ther. 2017;102:765–76.
4. Yu H, Steeghs N, Nijenhuis C, Schellens J, Beijnen J, Huitema A. Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets. Clin Pharmacokinet. 2014;53:305–25.
5. Beumer JH. Without therapeutic drug monitoring, there is no personalized cancer care. Clin Pharmacol Ther. 2013;93:228–30.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献